Intuitive Surgical, Inc. (NASDAQ:ISRG) Holdings Lowered by Elite Wealth Management Inc.

Elite Wealth Management Inc. trimmed its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 3.5% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 23,104 shares of the medical equipment provider’s stock after selling 831 shares during the period. Intuitive Surgical makes up 1.5% of Elite Wealth Management Inc.’s investment portfolio, making the stock its 9th largest holding. Elite Wealth Management Inc.’s holdings in Intuitive Surgical were worth $12,059,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds have also recently modified their holdings of the stock. M.E. Allison & CO. Inc. acquired a new stake in Intuitive Surgical during the 4th quarter worth $449,000. Seilern Investment Management Ltd acquired a new stake in Intuitive Surgical during the 4th quarter worth $82,517,000. Sycomore Asset Management boosted its stake in Intuitive Surgical by 27.4% during the 4th quarter. Sycomore Asset Management now owns 18,945 shares of the medical equipment provider’s stock worth $9,214,000 after purchasing an additional 4,079 shares during the period. Exome Asset Management LLC boosted its stake in Intuitive Surgical by 16.8% during the 3rd quarter. Exome Asset Management LLC now owns 7,427 shares of the medical equipment provider’s stock worth $3,649,000 after purchasing an additional 1,069 shares during the period. Finally, China Universal Asset Management Co. Ltd. boosted its stake in Intuitive Surgical by 5.6% during the 4th quarter. China Universal Asset Management Co. Ltd. now owns 9,843 shares of the medical equipment provider’s stock worth $5,138,000 after purchasing an additional 525 shares during the period. 83.64% of the stock is owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

A number of analysts recently weighed in on the stock. Royal Bank of Canada increased their price target on shares of Intuitive Surgical from $611.00 to $641.00 in a research note on Monday, January 27th. Piper Sandler restated an “overweight” rating and issued a $670.00 target price (up previously from $538.00) on shares of Intuitive Surgical in a research note on Friday, January 24th. UBS Group raised their target price on shares of Intuitive Surgical from $500.00 to $560.00 and gave the stock a “neutral” rating in a research note on Monday, January 27th. Jefferies Financial Group raised their target price on shares of Intuitive Surgical from $475.00 to $575.00 in a research note on Monday, January 27th. Finally, Stifel Nicolaus raised their target price on shares of Intuitive Surgical from $525.00 to $610.00 and gave the stock a “buy” rating in a research note on Thursday, December 5th. One research analyst has rated the stock with a sell rating, five have given a hold rating and sixteen have issued a buy rating to the company’s stock. According to MarketBeat, Intuitive Surgical has a consensus rating of “Moderate Buy” and a consensus price target of $613.10.

Insider Buying and Selling at Intuitive Surgical

In other Intuitive Surgical news, Director Amal M. Johnson sold 4,635 shares of the firm’s stock in a transaction dated Tuesday, January 28th. The shares were sold at an average price of $566.60, for a total transaction of $2,626,191.00. Following the completion of the transaction, the director now directly owns 12,275 shares in the company, valued at approximately $6,955,015. This trade represents a 27.41 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, CFO Jamie Samath sold 269 shares of Intuitive Surgical stock in a transaction dated Monday, February 10th. The stock was sold at an average price of $590.00, for a total transaction of $158,710.00. Following the sale, the chief financial officer now owns 3,282 shares of the company’s stock, valued at approximately $1,936,380. This trade represents a 7.58 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders sold 6,348 shares of company stock worth $3,587,582. 0.90% of the stock is owned by corporate insiders.

Intuitive Surgical Stock Down 2.4 %

Shares of NASDAQ ISRG opened at $591.79 on Friday. The firm has a 50-day moving average price of $565.45 and a 200 day moving average price of $524.52. Intuitive Surgical, Inc. has a 52 week low of $364.17 and a 52 week high of $616.00. The stock has a market capitalization of $210.78 billion, a price-to-earnings ratio of 92.32, a price-to-earnings-growth ratio of 5.87 and a beta of 1.39.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.